As Director of Clinical Operations, Leigh Abbott oversees the strategic and operational aspects of clinical drug development for Xynomic Pharmaceuticals globally.
Ms. Abbott comes to Xynomic with 16+ years of clinical operations experience including portfolio and program management, spanning across small and large pharmaceutical companies, as well as academic research and contract research organizations. Prior to joining Xynomic Pharmaceutical, Ms. Abbott worked with several companies, where she had increasing responsiblity including BioMarin, Pfizer, Forest Labs, Sanofi, Duke Clinical Research Institute, Syneos Health, Quintiles, PPD, and Advanced Clinical.
Ms. Abbott responsibilities have included the execution of clinical trial programs, from Phase I to IV, with a recent focus on Rare Disease and Immunotherapy in bladder cancer, as well as lung. Prior to her work in clinical research, Ms. Abbott practiced as a Pediatric registered nurse and is currently licensed in North Carolina.
Ms. Abbott received her BSN in Nursing from East Carolina University, as well as her Masters. Ms. Abbott was also certified in Pediatric Oncology.